Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2022 Filed Mar 15, 2022 20:45 UTC |
Fraser CraigDirector · President and CEO
|
PurchaseCommon Stock | 3,000 | $0.98 | $2,940.30 |
DisclosureSEC source: 0001437749-22-006313 · rdgdoc.xml · nonDerivative · entry 1 Fraser Craig · CIK 0001557420 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,058 Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 22:53 UTC |
Simonson StevenSVP, Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 99,600 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001437749-22-005424 · rdgdoc.xml · derivative · entry 3 Simonson Steven · CIK 0001624401 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,600 Underlying: Common Stock · 99,600 shares Expires 2032-03-04 F3 · derivative.exercise_date: This employee stock option shall vest and become exercisable with respect to one-twelfth of the total number of shares subject to the options on a quarterly basis (every three months) with the first vest date on May 31, 2022 provided that the reporting person remains in continuous service on each vesting date. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 22:53 UTC |
Simonson StevenSVP, Chief Medical Officer
|
GrantCommon Stock | 66,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-005424 · rdgdoc.xml · nonDerivative · entry 1 Simonson Steven · CIK 0001624401 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,602 F1 · shares: These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on February 28, 2023 provided that the reporting person remains in continuous service on each vesting date. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 22:52 UTC |
Hamill John P.SVP & CFO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 99,600 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001437749-22-005421 · rdgdoc.xml · derivative · entry 2 Hamill John P. · CIK 0001716213 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,600 Underlying: Common Stock · 99,600 shares Expires 2032-03-04 F2 · derivative.exercise_date: This employee stock option shall vest and become exercisable with respect to one-twelfth of the total number of shares subject to the options on a quarterly basis (every three months) with the first vest date on May 31, 2022 provided that the reporting person remains in continuous service on each vesting date. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 22:52 UTC |
Hamill John P.SVP & CFO
|
GrantCommon Stock | 66,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-005421 · rdgdoc.xml · nonDerivative · entry 1 Hamill John P. · CIK 0001716213 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,800 F1 · shares: These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on February 28, 2023 provided that the reporting person remains in continuous service on each vesting date. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 22:51 UTC |
Fraser CraigDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 250,400 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001437749-22-005417 · rdgdoc.xml · derivative · entry 3 Fraser Craig · CIK 0001557420 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,400 Underlying: Common Stock · 250,400 shares Expires 2032-03-04 F3 · derivative.exercise_date: This employee stock option shall vest and become exercisable with respect to one-twelfth of the total number of shares subject to the options on a quarterly basis (every three months) with the first vest date on May 31, 2022 provided that the reporting person remains in continuous service on each vesting date. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 22:51 UTC |
Fraser CraigDirector · President and CEO
|
GrantCommon Stock | 166,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-005417 · rdgdoc.xml · nonDerivative · entry 1 Fraser Craig · CIK 0001557420 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,058 F1 · shares: These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on February 28, 2023 provided that the reporting person remains in continuous service on each vesting date. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 22:48 UTC |
Curtis EricSVP & COO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 99,600 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001437749-22-005414 · rdgdoc.xml · derivative · entry 2 Curtis Eric · CIK 0001651755 · SVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,600 Underlying: Common Stock · 99,600 shares Expires 2032-03-04 F2 · derivative.exercise_date: This employee stock option shall vest and become exercisable with respect to one-twelfth of the total number of shares subject to the options on a quarterly basis (every three months) with the first vest date on May 31, 2022 provided that the reporting person remains in continuous service on each vesting date. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 22:48 UTC |
Curtis EricSVP & COO
|
GrantCommon Stock | 66,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-005414 · rdgdoc.xml · nonDerivative · entry 1 Curtis Eric · CIK 0001651755 · SVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,591 F1 · shares: These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on February 28, 2023 provided that the reporting person remains in continuous service on each vesting date. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 22:47 UTC |
CARMAN DIANESVP & General Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 99,600 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001437749-22-005412 · rdgdoc.xml · derivative · entry 2 CARMAN DIANE · CIK 0001871113 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,600 Underlying: Common Stock · 99,600 shares Expires 2032-03-04 F2 · derivative.exercise_date: This employee stock option shall vest and become exercisable with respect to one-twelfth of the total number of shares subject to the options on a quarterly basis (every three months) with the first vest date on May 31, 2022 provided that the reporting person remains in continuous service on each vesting date. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 22:47 UTC |
CARMAN DIANESVP & General Counsel
|
GrantCommon Stock | 66,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-005412 · rdgdoc.xml · nonDerivative · entry 1 CARMAN DIANE · CIK 0001871113 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,300 F1 · shares: These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on February 28, 2023 provided that the reporting person remains in continuous service on each vesting date. Read SEC document |
| December 30, 2021 Filed Jan 10, 2022 22:03 UTC |
Center Laboratories, Inc.10% owner
|
PurchaseCommon Stock | 1,239,088 | $1.60 | $1,982,540.80 |
DisclosureSEC source: 0001213900-22-001391 · ownership.xml · nonDerivative · entry 3 Center Laboratories, Inc. · CIK 0001770423 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,239,088 F3 · kind: On December 30, 2021, the Reporting Person purchased all remaining shares of Common Stock held by Bioengine Capital Inc., and now holds the shares directly. Read SEC document |
| December 30, 2021 Filed Jan 10, 2022 22:03 UTC |
Bioengine Capital Inc.10% owner
|
SaleCommon Stock | 1,239,088 | $1.60 | $1,982,540.80 |
DisclosureSEC source: 0001213900-22-001390 · ownership.xml · nonDerivative · entry 3 Bioengine Capital Inc. · CIK 0001770197 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · kind: On December 30, 2021, the Reporting Person sold all its remaining shares of Common Stock to Center Laboratories, Inc., which owns 58.6% of the Reporting Person. As a result of the foregoing transaction, the Reporting Person now directly owns 0 shares of Common Stock. F3 · ownership.direct: On December 30, 2021, the Reporting Person sold all its remaining shares of Common Stock to Center Laboratories, Inc., which owns 58.6% of the Reporting Person. As a result of the foregoing transaction, the Reporting Person now directly owns 0 shares of Common Stock. Read SEC document |
| November 19, 2021 Filed Nov 22, 2021 13:35 UTC |
Fraser CraigDirector · President and CEO
|
PurchaseCommon Stock | 930 | $1.60 | $1,488.00 |
DisclosureSEC source: 0001437749-21-027198 · rdgdoc.xml · nonDerivative · entry 1 Fraser Craig · CIK 0001557420 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,158 Read SEC document |
| November 18, 2021 Filed Nov 18, 2021 21:25 UTC |
Fraser CraigDirector · President and CEO
|
PurchaseCommon Stock | 930 | $1.61 | $1,497.30 |
DisclosureSEC source: 0001437749-21-027085 · rdgdoc.xml · nonDerivative · entry 1 Fraser Craig · CIK 0001557420 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,228 Read SEC document |
| October 22, 2021 Filed Oct 25, 2021 13:17 UTC |
Fraser CraigDirector · President and CEO
|
PurchaseCommon Stock | 3,000 | $1.90 | $5,700.00 |
DisclosureSEC source: 0001437749-21-024196 · rdgdoc.xml · nonDerivative · entry 1 Fraser Craig · CIK 0001557420 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,298 Read SEC document |
| October 19, 2021 Filed Oct 19, 2021 20:56 UTC |
Huang JamesDirector
|
PurchaseCommon Stock | 50,000 | $1.90 | $95,135.00 |
DisclosureSEC source: 0001437749-21-023912 · rdgdoc.xml · nonDerivative · entry 1 Huang James · CIK 0001573160 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,281 F1 · price: The shares were purchased in multiple trades at prices ranging from $1.84 to $1.93. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 19, 2021 Filed Oct 19, 2021 20:51 UTC |
Fraser CraigDirector · President and CEO
|
PurchaseCommon Stock | 3,000 | $1.91 | $5,730.00 |
DisclosureSEC source: 0001437749-21-023910 · rdgdoc.xml · nonDerivative · entry 1 Fraser Craig · CIK 0001557420 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,298 Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:05 UTC |
CARMAN DIANESVP & General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001437749-21-016434 · rdgdoc.xml · derivative · entry 1 CARMAN DIANE · CIK 0001871113 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2031-07-01 F1 · derivative.exercise_date: The stock option shall vest in three equal annual installments beginning on the first anniversary of the grant date. The stock option is an inducement grant pursuant to Nasdaq Listing Rule 5635(c)(4). Read SEC document |
| June 15, 2021 Filed Jun 18, 2021 00:03 UTC |
Huang JamesDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001437749-21-015119 · rdgdoc.xml · derivative · entry 3 Huang James · CIK 0001573160 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-06-15 F3 · derivative.exercise_date: The stock option shall vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 15, 2021 Filed Jun 18, 2021 00:02 UTC |
Geffken Daniel E.Director
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001437749-21-015118 · rdgdoc.xml · derivative · entry 2 Geffken Daniel E. · CIK 0001314756 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-06-15 F1 · derivative.exercise_date: The stock option shall vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| April 16, 2021 Filed Apr 19, 2021 11:49 UTC |
Hamill John P.SVP & CFO
|
PurchaseCommon Stock | 1,000 | $2.07 | $2,066.90 |
DisclosureSEC source: 0001437749-21-009187 · rdgdoc.xml · nonDerivative · entry 1 Hamill John P. · CIK 0001716213 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 F1 · price: The shares were purchased in multiple trades at prices ranging from $2.065 to $2.0685. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 11:44 UTC |
Fraser CraigDirector · President and CEO
|
PurchaseCommon Stock | 1,000 | $2.09 | $2,092.00 |
DisclosureSEC source: 0001437749-21-009306 · rdgdoc.xml · nonDerivative · entry 1 Fraser Craig · CIK 0001557420 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,298 F1 · price: The shares were purchased in multiple trades at prices ranging from $2.09 to $2.0933. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 11:47 UTC |
Fraser CraigDirector · President and CEO
|
PurchaseCommon Stock | 1,000 | $2.24 | $2,239.90 |
DisclosureSEC source: 0001437749-21-009186 · rdgdoc.xml · nonDerivative · entry 1 Fraser Craig · CIK 0001557420 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,298 Read SEC document |
| April 07, 2021 Filed Apr 8, 2021 20:16 UTC |
Curtis EricSVP & COO
|
PurchaseCommon Stock | 791 | $2.52 | $1,991.11 |
DisclosureSEC source: 0001437749-21-008559 · rdgdoc.xml · nonDerivative · entry 1 Curtis Eric · CIK 0001651755 · SVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,291 F1 · price: The shares were purchased in multiple trades at prices ranging from $2.515 to $2.5185. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 06, 2021 Filed Apr 7, 2021 20:18 UTC |
Fraser CraigDirector · President and CEO
|
PurchaseCommon Stock | 500 | $2.57 | $1,285.00 |
DisclosureSEC source: 0001437749-21-008459 · rdgdoc.xml · nonDerivative · entry 1 Fraser Craig · CIK 0001557420 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,298 Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 20:28 UTC |
Fraser CraigDirector · President and CEO
|
PurchaseCommon Stock | 1,000 | $2.58 | $2,579.90 |
DisclosureSEC source: 0001437749-21-008400 · rdgdoc.xml · nonDerivative · entry 1 Fraser Craig · CIK 0001557420 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,798 Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 12:06 UTC |
Fraser CraigDirector · President and CEO
|
PurchaseCommon Stock | 500 | $2.46 | $1,229.35 |
DisclosureSEC source: 0001437749-21-008159 · rdgdoc.xml · nonDerivative · entry 1 Fraser Craig · CIK 0001557420 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,798 Read SEC document |
| March 31, 2021 Filed Mar 31, 2021 20:30 UTC |
Fraser CraigDirector · President and CEO
|
PurchaseCommon Stock | 500 | $2.32 | $1,159.95 |
DisclosureSEC source: 0001437749-21-007852 · rdgdoc.xml · nonDerivative · entry 1 Fraser Craig · CIK 0001557420 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,298 Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:13 UTC |
Huang JamesDirector · 10% owner
|
PurchaseCommon Stock | 150,000 | $2.36 | $354,000.00 |
DisclosureSEC source: 0001437749-21-008134 · rdgdoc.xml · nonDerivative · entry 1 Huang James · CIK 0001573160 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,000 F1 · price: The shares were purchased in multiple trades at prices ranging from $2.275 to $2.40. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 25, 2021 Filed Mar 25, 2021 20:44 UTC |
Hamill John P.SVP & CFO
|
PurchaseCommon Stock Warrants · Derivative | 1,500 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001437749-21-007172 · rdgdoc.xml · derivative · entry 2 Hamill John P. · CIK 0001716213 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2026-03-25 F1 · price: Issued in connection with the purchase of shares of common stock on March 25, 2021 as reported above. Read SEC document |
| March 25, 2021 Filed Mar 25, 2021 20:44 UTC |
Hamill John P.SVP & CFO
|
PurchaseCommon Stock | 1,500 | $3.25 | $4,875.00 |
DisclosureSEC source: 0001437749-21-007172 · rdgdoc.xml · nonDerivative · entry 1 Hamill John P. · CIK 0001716213 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Read SEC document |
| March 25, 2021 Filed Mar 25, 2021 20:45 UTC |
Simonson StevenSVP, Chief Medical Officer
|
PurchaseCommon Stock Warrants · Derivative | 1,500 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001437749-21-007173 · rdgdoc.xml · derivative · entry 3 Simonson Steven · CIK 0001624401 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2026-03-25 F2 · price: Issued in connection with the purchase of shares of common stock on March 25, 2021 as reported above. Read SEC document |
| March 25, 2021 Filed Mar 25, 2021 20:45 UTC |
Simonson StevenSVP, Chief Medical Officer
|
PurchaseCommon Stock | 1,500 | $3.25 | $4,875.00 |
DisclosureSEC source: 0001437749-21-007173 · rdgdoc.xml · nonDerivative · entry 1 Simonson Steven · CIK 0001624401 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,302 Read SEC document |
| March 25, 2021 Filed Mar 25, 2021 20:43 UTC |
Fraser CraigDirector · President and CEO
|
PurchaseCommon Stock Warrants · Derivative | 1,500 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001437749-21-007171 · rdgdoc.xml · derivative · entry 3 Fraser Craig · CIK 0001557420 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2026-03-25 F2 · price: Issued in connection with the purchase of shares of common stock on March 25, 2021 as reported above. Read SEC document |
| March 25, 2021 Filed Mar 25, 2021 20:43 UTC |
Fraser CraigDirector · President and CEO
|
PurchaseCommon Stock | 1,500 | $3.25 | $4,875.00 |
DisclosureSEC source: 0001437749-21-007171 · rdgdoc.xml · nonDerivative · entry 1 Fraser Craig · CIK 0001557420 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,798 Read SEC document |
| February 03, 2021 Filed Feb 6, 2021 02:14 UTC |
PEACOCK BRUCEDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-21-002149 · rdgdoc.xml · derivative · entry 2 PEACOCK BRUCE · CIK 0001228459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock options shall vest as follows: 1/3 vested immediately on the grant date, 1/3 shall vest on the first anniversary of the grant date and 1/3 shall vest on the second anniversary of the grant date. Read SEC document |
| February 03, 2021 Filed Feb 6, 2021 02:13 UTC |
Huang JamesDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-21-002148 · rdgdoc.xml · derivative · entry 4 Huang James · CIK 0001573160 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-02-03 F3 · derivative.exercise_date: The stock options shall vest as follows: 1/3 vested immediately on the grant date, 1/3 shall vest on the first anniversary of the grant date and 1/3 shall vest on the second anniversary of the grant date. Read SEC document |
| February 03, 2021 Filed Feb 6, 2021 02:11 UTC |
Geffken Daniel E.Director
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-21-002147 · rdgdoc.xml · derivative · entry 2 Geffken Daniel E. · CIK 0001314756 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock option shall vest as follows: 1/3 vested immediately on the grant date, 1/3 shall vest on the first anniversary of the grant date and 1/3 shall vest on the second anniversary of the grant date. Read SEC document |
| February 03, 2021 Filed Feb 6, 2021 02:09 UTC |
Schreiber Brian DDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-21-002146 · rdgdoc.xml · derivative · entry 2 Schreiber Brian D · CIK 0001762945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock options were fully vested and exercisable on the grant date. Read SEC document |
| February 03, 2021 Filed Feb 6, 2021 02:08 UTC |
Joseph Mahady MDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-21-002145 · rdgdoc.xml · derivative · entry 2 Joseph Mahady M · CIK 0001187302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock options were fully vested and exercisable on the grant date. Read SEC document |
| February 03, 2021 Filed Feb 6, 2021 02:05 UTC |
Leone John RDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-21-002144 · rdgdoc.xml · derivative · entry 2 Leone John R · CIK 0001301047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock options were fully vested and exercisable on the grant date. Read SEC document |
| February 03, 2021 Filed Feb 6, 2021 02:03 UTC |
Williams Leslie J.Director
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-21-002142 · rdgdoc.xml · derivative · entry 1 Williams Leslie J. · CIK 0001770465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock option shall vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 03, 2021 Filed Feb 6, 2021 02:01 UTC |
Loh EvanDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-21-002140 · rdgdoc.xml · derivative · entry 1 Loh Evan · CIK 0001622680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock option shall vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 03, 2021 Filed Feb 9, 2021 21:25 UTC |
SCOTT ROBERT ADirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-21-002339 · rdgdoc.xml · derivative · entry 1 SCOTT ROBERT A · CIK 0001248520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock option shall vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 21:39 UTC |
Simonson StevenSVP, Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $5.44 | $0.00 |
DisclosureSEC source: 0001437749-21-001286 · rdgdoc.xml · derivative · entry 4 Simonson Steven · CIK 0001624401 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2031-01-22 F3 · derivative.exercise_date: This employee stock option shall vest in a series of three successive, equal installments beginning with the first anniversary of the grant date. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 21:39 UTC |
Simonson StevenSVP, Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 52,600 | $0.00 Strike: $5.44 | $0.00 |
DisclosureSEC source: 0001437749-21-001286 · rdgdoc.xml · derivative · entry 3 Simonson Steven · CIK 0001624401 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,600 Underlying: Common Stock · 52,600 shares Expires 2031-01-22 F2 · derivative.exercise_date: This employee stock option shall vest in a series of three successive, equal installments on the grant date and the first and second anniversaries of the grant date. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 21:35 UTC |
Hamill John P.SVP & CFO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $5.44 | $0.00 |
DisclosureSEC source: 0001437749-21-001284 · rdgdoc.xml · derivative · entry 2 Hamill John P. · CIK 0001716213 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2031-01-22 F1 · derivative.exercise_date: This employee stock option shall vest in a series of three successive, equal installments beginning with the first anniversary of the grant date. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 21:34 UTC |
Fraser CraigDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 143,250 | $0.00 Strike: $5.44 | $0.00 |
DisclosureSEC source: 0001437749-21-001282 · rdgdoc.xml · derivative · entry 4 Fraser Craig · CIK 0001557420 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,250 Underlying: Common Stock · 143,250 shares Expires 2031-01-22 F3 · derivative.exercise_date: This employee stock option shall vest in a series of three successive, equal installments beginning with the first anniversary of the grant date. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 21:34 UTC |
Fraser CraigDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 143,250 | $0.00 Strike: $5.44 | $0.00 |
DisclosureSEC source: 0001437749-21-001282 · rdgdoc.xml · derivative · entry 3 Fraser Craig · CIK 0001557420 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,250 Underlying: Common Stock · 143,250 shares Expires 2031-01-22 F2 · derivative.exercise_date: This employee stock option shall vest in a series of three successive, equal installments on the grant date and the first and second anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.